160 related articles for article (PubMed ID: 21239607)
1. Aggravation of bleomycin-induced pulmonary inflammation and fibrosis in mice lacking peroxiredoxin I.
Kikuchi N; Ishii Y; Morishima Y; Yageta Y; Haraguchi N; Yamadori T; Masuko H; Sakamoto T; Yanagawa T; Warabi E; Ishii T; Hizawa N
Am J Respir Cell Mol Biol; 2011 Sep; 45(3):600-9. PubMed ID: 21239607
[TBL] [Abstract][Full Text] [Related]
2. C-C chemokine receptor 2 (CCR2) deficiency improves bleomycin-induced pulmonary fibrosis by attenuation of both macrophage infiltration and production of macrophage-derived matrix metalloproteinases.
Okuma T; Terasaki Y; Kaikita K; Kobayashi H; Kuziel WA; Kawasuji M; Takeya M
J Pathol; 2004 Dec; 204(5):594-604. PubMed ID: 15538737
[TBL] [Abstract][Full Text] [Related]
3. Bleomycin-induced pulmonary fibrosis is attenuated in gamma-glutamyl transpeptidase-deficient mice.
Pardo A; Ruiz V; Arreola JL; RamÃrez R; Cisneros-Lira J; Gaxiola M; Barrios R; Kala SV; Lieberman MW; Selman M
Am J Respir Crit Care Med; 2003 Mar; 167(6):925-32. PubMed ID: 12468440
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic effects of evasin-1, a chemokine binding protein, in bleomycin-induced pulmonary fibrosis.
Russo RC; Alessandri AL; Garcia CC; Cordeiro BF; Pinho V; Cassali GD; Proudfoot AE; Teixeira MM
Am J Respir Cell Mol Biol; 2011 Jul; 45(1):72-80. PubMed ID: 20833968
[TBL] [Abstract][Full Text] [Related]
5. Long-acting human serum albumin-thioredoxin fusion protein suppresses bleomycin-induced pulmonary fibrosis progression.
Tanaka R; Watanabe H; Kodama A; Chuang VT; Ishima Y; Hamasaki K; Tanaka K; Mizushima T; Otagiri M; Maruyama T
J Pharmacol Exp Ther; 2013 May; 345(2):271-83. PubMed ID: 23442250
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance.
Kikuchi N; Ishii Y; Morishima Y; Yageta Y; Haraguchi N; Itoh K; Yamamoto M; Hizawa N
Respir Res; 2010 Mar; 11(1):31. PubMed ID: 20298567
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of pulmonary fibrosis by the chemokine IP-10/CXCL10.
Tager AM; Kradin RL; LaCamera P; Bercury SD; Campanella GS; Leary CP; Polosukhin V; Zhao LH; Sakamoto H; Blackwell TS; Luster AD
Am J Respir Cell Mol Biol; 2004 Oct; 31(4):395-404. PubMed ID: 15205180
[TBL] [Abstract][Full Text] [Related]
8. Thrombin-activatable fibrinolysis inhibitor deficiency attenuates bleomycin-induced lung fibrosis.
Fujimoto H; Gabazza EC; Taguchi O; Nishii Y; Nakahara H; Bruno NE; D'Alessandro-Gabazza CN; Kasper M; Yano Y; Nagashima M; Morser J; Broze GJ; Suzuki K; Adachi Y
Am J Pathol; 2006 Apr; 168(4):1086-96. PubMed ID: 16565485
[TBL] [Abstract][Full Text] [Related]
9. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta.
Kalayarasan S; Sriram N; Sudhandiran G
Life Sci; 2008 Jun; 82(23-24):1142-53. PubMed ID: 18462759
[TBL] [Abstract][Full Text] [Related]
10. [Effects of andrographolide on the concentration of cytokines in BALF and the expressions of type I and III collagen mRNA in lung tissue in bleomycin-induced rat pulmonary fibrosis].
Zhu HL; Huang CL; Wang WJ; Zhan XQ; Fan XM
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jul; 27(7):725-9. PubMed ID: 21722520
[TBL] [Abstract][Full Text] [Related]
11. Biphasic effects of free radical scavengers against bleomycin-induced pulmonary fibrosis.
Fujita M; Mizuta Y; Ikegame S; Ouchi H; Ye Q; Harada E; Inoshima I; Yoshimi M; Watanabe K; Nakanishi Y
Pulm Pharmacol Ther; 2008 Oct; 21(5):805-11. PubMed ID: 18655842
[TBL] [Abstract][Full Text] [Related]
12. The transcription factor NRF2 protects against pulmonary fibrosis.
Cho HY; Reddy SP; Yamamoto M; Kleeberger SR
FASEB J; 2004 Aug; 18(11):1258-60. PubMed ID: 15208274
[TBL] [Abstract][Full Text] [Related]
13. VEGFR-2 antagonist SU5416 attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Li WC; Liu DS; Li YP; Wen FQ; Feng YL; Zhang SF; Huang XY; Wang T; Wang K; Wang X; Chen L
Int Immunopharmacol; 2009 Jan; 9(1):70-9. PubMed ID: 18976720
[TBL] [Abstract][Full Text] [Related]
14. Simvastatin attenuates bleomycin-induced pulmonary fibrosis in mice.
Ou XM; Feng YL; Wen FQ; Huang XY; Xiao J; Wang K; Wang T
Chin Med J (Engl); 2008 Sep; 121(18):1821-9. PubMed ID: 19080365
[TBL] [Abstract][Full Text] [Related]
15. Effects of Th2 pulmonary inflammation in mice with bleomycin-induced pulmonary fibrosis.
Hirata H; Arima M; Fukushima Y; Ishii Y; Tokuhisa T; Fukuda T
Respirology; 2008 Nov; 13(6):788-98. PubMed ID: 18811877
[TBL] [Abstract][Full Text] [Related]
16. An essential role for CCAAT/enhancer binding protein beta in bleomycin-induced pulmonary fibrosis.
Hu B; Ullenbruch MR; Jin H; Gharaee-Kermani M; Phan SH
J Pathol; 2007 Mar; 211(4):455-62. PubMed ID: 17177178
[TBL] [Abstract][Full Text] [Related]
17. Fluorofenidone attenuates bleomycin-induced pulmonary inflammation and fibrosis in mice via restoring caveolin 1 expression and inhibiting mitogen-activated protein kinase signaling pathway.
Meng J; Zou Y; Hu C; Zhu Y; Peng Z; Hu G; Wang Z; Tao L
Shock; 2012 Nov; 38(5):567-73. PubMed ID: 23042199
[TBL] [Abstract][Full Text] [Related]
18. Heat shock protein 70 protects against bleomycin-induced pulmonary fibrosis in mice.
Tanaka K; Tanaka Y; Namba T; Azuma A; Mizushima T
Biochem Pharmacol; 2010 Sep; 80(6):920-31. PubMed ID: 20513440
[TBL] [Abstract][Full Text] [Related]
19. Effect of granulocyte colony-stimulating factor on bleomycin-induced acute lung injury and pulmonary fibrosis.
Azoulay E; Herigault S; Levame M; Brochard L; Schlemmer B; Harf A; Delclaux C
Crit Care Med; 2003 May; 31(5):1442-8. PubMed ID: 12771616
[TBL] [Abstract][Full Text] [Related]
20. Toll like receptor 2 mediates bleomycin-induced acute lung injury, inflammation and fibrosis in mice.
Liu HZ; Yang HZ; Mi S; Cui B; Hua F; Hu ZW
Yao Xue Xue Bao; 2010 Aug; 45(8):976-86. PubMed ID: 21348427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
